Q-Med AB: Invitation to interim report conference call January-September 2008

Time: Friday, October 24, 2008 at 10.00 a.m. CET.

To join the conference:
Swedish dial in number: + 46 (0)8 505 201 10
UK dial in number: +44 (0)20 7162 0025

Q-Med participants:
Bengt Ågerup, President and CEO
Alexander Kotsinas, Vice President and CFO
Madelene Sandgren, Director Investor Relations and Corporate Communications

The press release for Q-Med AB’s interim report will be released approximately
08.00 a.m on October 24, 2008.

The slide presentation will be available at:
www.q-med.com / Investors / Presentations

A recorded version of the presentation will be available for seven working days on
tel: +44 (0)20 7031 4064, access code: 81 34 11.

Queries should be addressed to:
Madelene Sandgren, Director Investor Relations and Corporate Communications,
Tel: + 46 (0)70 974 90 15

About Us

Q-Med is a rapidly growing and profitable biotechnology and medical device company that develops, produces and markets medical implants. Operations focus on four areas, Esthetics, Orthopedics, Uro-Gynecology, and Cell Therapy and Encapsulation.

Documents & Links